The Mexican consensus on nonalcoholic fatty liver disease

被引：40

作者：

Bernal-Reyes, R. ^{[1
]}

Castro-Narro, G. ^{[2
]}

Male-Velazquez, R. ^{[3
]}

Carmona-Sanchez, R. ^{[4
]}

Gonzalez-Huezo, M. S. ^{[5
]}

Garcia-Juarez, I. ^{[2
]}

Chavez-Tapia, N. ^{[6
]}

Aguilar-Salinas, C. ^{[7
]}

Aiza-Haddad, I. ^{[8
]}

Ballesteros-Amozurrutia, M. A. ^{[9
]}

Bosques-Padilla, F. ^{[10
]}

Castillo-Barradas, M. ^{[11
]}

Chavez-Barrera, J. A. ^{[12
]}

Cisneros-Garza, L. ^{[13
]}

Flores-Calderon, J. ^{[14
]}

Garcia-Compean, D. ^{[13
]}

Gutierrez-Grobe, Y. ^{[6
]}

Higuera de la Tijera, M. F. ^{[15
]}

Kershenobich-Stalnikowitz, D. ^{[7
]}

Ladron de Guevara-Cetina, L. ^{[16
]}

Lizardi-Cervera, J. ^{[6
]}

Lopez-Cossio, J. A. ^{[5
]}

Martinez-Vazquez, S. ^{[2
]}

Marquez-Guillen, E. ^{[7
]}

Mendez-Sanchez, N. ^{[6
]}

Moreno-Alcantar, R. ^{[17
]}

Poo-Ramirez, J. L. ^{[18
]}

Ramos-Martinez, P. ^{[19
]}

Rodriguez-Hernandez, H. ^{[20
]}

Sanchez-Avila, J. F. ^{[21
]}

Stoopen-Rometti, M. ^{[22
]}

Torre-Delgadillo, A. ^{[2
]}

Torres-Villalobos, G. ^{[7
]}

Trejo-Estrada, R. ^{[23
]}

Uribe-Esquivel, M. ^{[6
]}

Velarde-Ruiz Valazco, J. A. ^{[24
]}

机构：

[1] Soc Espanola Beneficencia, Pachuca, Hidalgo, Mexico

[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Gastroenterol, Mexico City, DF, Mexico

[3] Inst Salud Digest & Hepat SA CV, Guadalajara, Jalisco, Mexico

[4] Consulta Privada, San Luis Potosi, Mexico

[5] ISSSEMYM, Serv Gastroenterol & Endoscopia GI, Metepec, Estado De Mexic, Mexico

[6] Fdn Clin Med Sur, Serv Gastroenterol, Mexico City, DF, Mexico

[7] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico

[8] Hosp Angeles Lomas, Clin Enfermedades Hepat, Mexico City, DF, Mexico

[9] Hosp Angeles Pedregal, Mexico City, DF, Mexico

[10] Ctr Med Zambrano Hell, Monterrey, Nuevo Leon, Mexico

[11] Hosp Especialidades Ctr Med La Raza, Ctr Med La Raza IMSS, Serv Gastroenterol, Mexico City, DF, Mexico

[12] IMSS, Ctr Med La Raza, Serv Gastroenterol Pediat, Hosp Gen, Mexico City, DF, Mexico

[13] Hosp Univ UANL, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico

[14] IMSS, Ctr Med Siglo 21, Hosp Pediat, Serv Gastroenterol, Mexico City, DF, Mexico

[15] Hosp Gen Mexico City, Serv Gastroenterol, Mexico City, DF, Mexico

[16] Hosp Angeles Clin Londres, Mexico City, DF, Mexico

[17] Hosp Especialidades Ctr Med La Raza, Ctr Med Siglo 21, IMSS, Serv Gastroenterol, Mexico City, DF, Mexico

[18] Tec Monterrey, Ctr Innovac & Educ Ejecut, Mexico City, DF, Mexico

[19] Ctr Patol Especializada SLP, San Luis Potosi, Mexico

[20] Hosp Especialidades Ctr Med La Raza, United Invest Biomed AMCCI, Durango, Mexico

[21] Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey, Nuevo Leon, Mexico

[22] Ctr Diagnost CT Scanner Lomas Altas, Mexico City, DF, Mexico

[23] Ctr Med ABC, Mexico City, DF, Mexico

[24] Hosp Civil Guadalajara, Dept Gastroenterol, Guadalajara, Jalisco, Mexico

来源：

REVISTA DE GASTROENTEROLOGIA DE MEXICO | 2019年 / 84卷 / 01期

关键词：

Nonalcoholic fatty liver disease; Mexican consensus; CONTROLLED TRANSIENT ELASTOGRAPHY; INTRAHEPATIC LIPID-CONTENT; PLACEBO-CONTROLLED TRIAL; MAGNETIC-RESONANCE ELASTOGRAPHY; HEPATOCELLULAR-CARCINOMA HCC; DE-NOVO LIPOGENESIS; LONG-TERM OUTCOMES; VITAMIN-E; CRYPTOGENIC CIRRHOSIS; INSULIN-RESISTANCE;

D O I：

10.1016/j.rgmx.2018.11.007

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Nonalcoholic fatty liver disease (NAFLD) affects nearly one third of the population worldwide. Mexico is one of the countries whose population has several risk factors for the disease and its prevalence could surpass 50%. If immediate action is not taken to counteract what is now considered a national health problem, the medium-term panorama will be very bleak. This serious situation prompted the Asociacion Mexicana de Gastroenterologia and the Asociacion Mexicana de Hepatologia to produce the Mexican Consensus on Fatty Liver Disease. It is an up-to-date and detailed review of the epidemiology, pathaphysialogy, clinical forms, diagnosis, and treatment of the disease, whose aim is to provide the Mexican physician with a useful tool for the prevention and management of nonalcoholic fatty Liver disease. (C) 2019 Asociacion Mexicana de Gastroenterologia. Published by Masson Doyma Mexico S.A.

引用

页码：69 / 99

页数：31

共 50 条

[1] Nonalcoholic Fatty Liver Disease Is Related to Nonalcoholic Fatty Pancreas Disease
van Geenen, Erwin-Jan M.
Smits, Mark M.
Schreuder, Tim C. M. A.
van der Peet, Donald L.
Bloemena, Elisabeth
Mulder, Chris J. J.
PANCREAS, 2010, 39 (08) : 1185 - 1190
[2] Nonalcoholic fatty liver disease
Alfie, ME
Treem, WR
PEDIATRIC ANNALS, 2006, 35 (04): : 290 - +
[3] Nonalcoholic fatty liver disease
Bayard, Max
Holt, Jim
Boroughs, Eileen
AMERICAN FAMILY PHYSICIAN, 2006, 73 (11) : 1961 - 1968
[4] Nonalcoholic fatty liver disease
Clark, JM
Brancati, FL
Diehl, AM
GASTROENTEROLOGY, 2002, 122 (06) : 1649 - 1657
[5] Nonalcoholic fatty liver disease
Nature Reviews Disease Primers, 1 (1)
[6] Nonalcoholic Fatty Liver Disease
Wang, Xiao Jing
Malhi, Harmeet
ANNALS OF INTERNAL MEDICINE, 2018, 169 (09) : ITC65 - ITC80
[7] Nonalcoholic Fatty Liver Disease
Sweet, Patrick H.
Khoo, Teresa
Nguyen, Steven
PRIMARY CARE, 2017, 44 (04): : 599 - +
[8] Nonalcoholic Fatty Liver Disease
Fitzgerald, Margaret A.
NURSE PRACTITIONER, 2007, 32 (02): : 6 - 7
[9] Nonalcoholic fatty liver disease
Elizabeth M. Brunt
Vincent W.-S. Wong
Valerio Nobili
Christopher P. Day
Silvia Sookoian
Jacquelyn J. Maher
Elisabetta Bugianesi
Claude B. Sirlin
Brent A. Neuschwander-Tetri
Mary E. Rinella
Nature Reviews Disease Primers, 1
[10] Nonalcoholic fatty liver disease
Madan, P
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 173 (07) : 734 - 735

← 1 2 3 4 5 →